Breaking News

QPharma Appoints DEA Director

By Kristin Brooks | March 19, 2014

Crusan brings extensive compliance experience

Matt Crusan has been appointed director of DEA Compliance and Services at QPharma. Mr. Crusan has served as a diversion investigator with the Drug Enforcement Administration (DEA), and brings extensive knowledge of DEA regulatory policy to QPharma’s newly established DEA compliance practice.
 
Mr. Crusan joins the company from the Pharma Compliance Group, where he served as director of regulatory affairs providing DEA compliance consulting services to manufacturers, distributors, hospitals, and retail pharmacy chains. Mr. Crusan also has experience conducting enterprise-wide DEA gap analyses and development of Suspicious Order & Monitoring (SOM) programs for drug wholesalers and manufacturers.
 
The new DEA compliance practice will include offerings including mock DEA audits and inspections, due diligence/diversion analysis, Standard Operating Procedure review, and physician risk analysis.
 
“Matt’s outstanding credentials and breadth of experience speak for themselves,” said QPharma president and chief executive officer Patrick P. Den Boer. “We are pleased to welcome him to our Professional Services team.”

blog comments powered by Disqus
  • Cold Chain Packaging Trends

    Cold Chain Packaging Trends

    Kristin Brooks, Contract Pharma||February 4, 2016
    Susan Li of UPS discusses supply chain trends, challenges, and packaging innovations

  • Packaging Equipment Trends Preview

    Packaging Equipment Trends Preview

    Kristin Brooks, Contract Pharma||January 26, 2016
    Christian Treitel of Bosch Packaging Technology discusses trends and capabilities

  • Tackling Drug Serialization Challenges

    Tackling Drug Serialization Challenges

    Tim Wright, editor||January 22, 2016
    Siemens and Adents together will develop a combined hardware plus software solution for pharma industry

  • CMC Biologics: Growing Through Innovation

    Tim Wright, Editor||January 28, 2016
    The new chief exec talks about industry trends and growth plans.

  • Cold-Chain Logistics & The Central Lab

    Kristin Brooks, Associate Editor||January 28, 2016
    Eric Hayashi of LabConnect discusses safety measures to ensure sample integrity

  • A Look at DCAT Week ‘16

    Tim Wright, Editor||January 28, 2016
    On the pulse of the pharmaceutical manufacturing value chain, DCAT Week ‘16 will deliver top-flight education programs and networking events.